How Russian COVID Vaccine will Influence the Stock Market

By |

Watch

Midas Letter

The Digital Businesss Channel for Cannabis, Crypto and Technology Stocks.

Midas Letter is provided as a source of information only, and is in no way to be construed as investment advice. James West, the author and publisher of the Midas Letter, is not authorized to provide investor advice, and provides this information only to readers who are interested in knowing what he is investing in and how he reaches such decisions.

Investing in emerging public companies involves a high degree of risk and investors in such companies could lose all their money. Always consult a duly accredited investment professional in your jurisdiction prior to making any investment decision.

Midas Letter occasionally accepts fees for advertising and sponsorship from public companies featured on this site. James West and/or Midas Letter may also receive compensation from companies affiliated with companies featured on this site. James West and/or Midas Letter also invests in companies on this site and so readers should view all information on this site as biased.

Russian President Vladimir Putin has declared that he has registered an effective coronavirus vaccine!

Allegedly, one of his daughters has already received it and production is about to get underway. Whether you believe the effectiveness of the vaccine or not, this does pose important questions on how the stock market will react to such positive news.

The big hope is that the world will go back to “normal”. The question then is not if, but when a successful vaccine will materialize, and whether you can make money while we wait for that to happen.

We have seen a massive bull market on the back on mostly negative news: bad economic data, COVID cases increasing, global geopolitical tensions, etc… So it will be interesting to see the price action if there is actually some good news. Will this send the stock market into all-time highs or is the market already overly extended?

Watch the full interview to learn to profit from COVID vaccine news and the hot sectors to invest in right now.

Midas Letter is provided as a source of information only, and is in no way to be construed as investment advice. James West, the author and publisher of the Midas Letter, is not authorized to provide investor advice, and provides this information only to readers who are interested in knowing what he is investing in and how he reaches such decisions.

Investing in emerging public companies involves a high degree of risk and investors in such companies could lose all their money. Always consult a duly accredited investment professional in your jurisdiction prior to making any investment decision.

Midas Letter occasionally accepts fees for advertising and sponsorship from public companies featured on this site. James West and/or Midas Letter may also receive compensation from companies affiliated with companies featured on this site. James West and/or Midas Letter also invests in companies on this site and so readers should view all information on this site as biased.